Page 10 - ப்ரிஸ்க்ரிப்ஶந் மருந்து பயனர் கட்டணம் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit July 31, 2021 GMT SAN DIEGO (BUSINESS WIRE) Jul 30, 2021 Robbins Geller Rudman & Dowd LLP announces that purchasers of Ardelyx Inc. (NASDAQ: ARDX) securities between August 6, 2020 and July 19, 2021, inclusive (“Class Period”) have until September 28, 2021 to seek appointment as lead plaintiff in the Ardelyx class action lawsuit. The Ardelyx class action lawsuit charges Ardelyx and certain of its top executives with violations of the Securities Exchange Act of 1934. The Ardelyx class action lawsuit was commenced on July 30, 2021 in the Northern District of California and is captioned

United statesSan diegoRobbins gellerEnron corpRobbins geller rudman dowdSecurities class action services topSecurities exchangeDrug administrationArdelyx incSecurities exchange actNorthern districtNew drug applicationPrescription drug user fee actClass periodPrivate securities litigation reform actRobbins geller rudman